Disclosure of a transparency notification from AOC Pharma S.à r.l. Regulated information Nazareth (Belgium)/Rotterdam (The Netherlands), 27 02 2026 – 6PM CET Disclosure of a transparency notification from AOC Pharma S.à r.l. Pursuant to the Belgian Act of 2 May 2007 on the disclosure of major shareholdings in listed companies, Fagron received a transparency notification from AOC Pharma S.à r.l., dated 24 February 2026. Notification from AOC Pharma S.à r.l. On 24 February 2026, Fagron received a transparency notification from AOC Pharma S.à r.l., informing the Company that its sharehold...
Openbaarmaking van transparantiekennisgeving van AOC Pharma S.à r.l. Gereglementeerde informatie Nazareth (België)/Rotterdam (Nederland), 27 februari 2026 – 18:00 CET Openbaarmaking van transparantiekennisgeving van AOC Pharma S.à r.l. Overeenkomstig de Belgische Wet van 2 mei 2007 op de openbaarmaking van belangrijke deelnemingen in beursgenoteerde vennootschappen, ontving Fagron een transparantiekennisgeving van AOC Pharma S.à r.l., gedateerd 24 februari 2026. Kennisgeving van AOC Pharma S.à r.l. Op 24 februari 2026 ontving Fagron een transparantiekennisgeving van AOC Pharma S.à r.l....
NOTICE OF ORDINARY AND EXTRAORDINARY GENERAL MEETINGS OF SHAREHOLDERS OF ECONOCOM SE OF 31 MARCH 2026 The shareholders are invited to attend the ordinary general meeting of Econocom Group SE, with registered office at Place du Champ de Mars 5, 1050 Brussels, Belgium, registered with the Crossroads Bank for Enterprises under number 0422.646.816 (the "Company"), to be held on Tuesday 31 March 2026 at 2 p.m. (Belgian time) at the Company's registered office. The Ordinary General Meeting will be followed by an Extraordinary General Meeting (together the "Meetings"). AGENDA AND PROPOSED RESOLUT...
CONVOCATION AUX ASSEMBLÉES GÉNÉRALES ORDINAIRE ET EXTRAORDINAIRE DES ACTIONNAIRES D’ECONOCOM SE DU 31 MARS 2026 Les actionnaires sont invités à assister à l’assemblée générale ordinaire de la société Econocom Group SE, ayant son siège Place du Champ de Mars 5 à 1050 Bruxelles, Belgique, enregistrée auprès de la Banque-Carrefour des Entreprises sous le numéro 0422.646.816 (la "Société") qui se tiendra le mardi 31 mars 2026 à 14 heures (heure belge) au siège de la Société. L'assemblée générale ordinaire sera suivie d'une assemblée générale extraordinaire (ensemble les "Assemblées"). ORDRE ...
OPROEPING TOT DE GEWONE EN BUITENGEWONE ALGEMENE VERGADERINGEN VAN AANDEELHOUDERS VAN ECONOCOM SE VAN 31 MAART 2026 De aandeelhouders worden uitgenodigd om deel te nemen aan de gewone algemene vergadering van de vennootschap Econocom Group SE, met maatschappelijke zetel te Marsplein 5 te 1050 Brussel, België, geregistreerd bij de Kruispuntbank van Ondernemingen onder nummer 0422.646.816 (de "Vennootschap"), die zal plaatsvinden op dinsdag 31 maart 2026 om 14 uur (Belgische tijd) op de zetel van de Vennootschap. De gewone algemene vergadering zal worden gevolgd door een buitengewone algemene...
ING publishes agenda and proxy materials for 2026 AGM ING publishes agenda and proxy materials for 2026 AGM ING today published the agenda and proxy materials for the 2026 Annual General Meeting (AGM) to be held on Tuesday 14 April 2026. The agenda includes the proposed appointment of Ida Lerner as Chief Financial Officer and member of the Executive Board, succeeding Tanate Phutrakul. Shareholders will also vote on updated remuneration policies for the Executive Board and Supervisory Board. Full details of all agenda items are included in the proxy materials for our AGM. The proxy materi...
Ackermans & van Haaren: Results capping already strong subsidiary reporting. DPS beat. Fagron: Acquisition of Pharmavit Europe, active in nutraceutical raw materials. Fugro: Patience please. Kendrion: Sees signs of improvement in EU economy. Proximus: 2026 dividend halved, 2028-30 targets a bit better on lower capex. Proximus: 4Q25 in line EBITDA on weaker sales, FCF up; 2026 guidance below on EBITDA. Recticel: Strong FY25 results, CEO transition seen as a negative
Fagron completes strategic acquisition of Pharmavit Europe, strengthening its leadership in high‑growth nutraceutical ingredients across EMEA Regulated information – inside information Nazareth (Belgium)/Rotterdam (The Netherlands), 26 February 2026 – 6:30PM Fagron completes strategic acquisition of Pharmavit Europe, strengthening its leadership in high‑growth nutraceutical ingredients across EMEA Fagron, the leading global player in pharmaceutical compounding, announces that it has completed the acquisition of Pharmavit Europe, a leading European distributor of nutraceutical raw material...
Fagron voltooit strategische overname van Pharmavit Europe en versterkt daarmee haar leiderschap in snelgroeiende nutraceutische ingrediënten in EMEA Gereglementeerde informatie - voorwetenschapNazareth (België)/Rotterdam (Nederland), 26 februari 2026 – 18:30 Fagron voltooit strategische overname van Pharmavit Europe en versterkt daarmee haar leiderschap in snelgroeiende nutraceutische ingrediënten in EMEA Fagron, de toonaangevende wereldwijde speler in farmaceutische bereidingen, kondigt de afronding aan van de overname van Pharmavit Europe, een toonaangevende Europese distributeur van ...
ING publishes 2025 Annual Report on Form 20-F ING publishes 2025 Annual Report on Form 20-F ING filed today its Annual Report on Form 20-F for the year ended 31 December 2025 with the United States Securities and Exchange Commission (SEC). The 2025 Form 20-F will be available on the ING website and can be downloaded from the SEC website (sec.gov) today. Shareholders or holders of ADRs can also request a hard copy of ING’s audited financial statements, free of charge, at . Note for editors For more on ING, please visit . Frequent news updates can be found in the . Photos of ING operations...
ING publishes 2025 Annual Report ING publishes 2025 Annual Report ING today published its 2025 Annual Report, giving stakeholders insight into our strategy, business activities and performance over the past year. Our activities are presented in the context of our strategic priorities: providing superior value to customers and putting sustainability at the heart of what we do. “As a bank, we have performed well across a wide range of metrics against a challenging and eventful backdrop. We are grateful that this resilience has been recognised by our shareholders, clients and employees,” wr...
A director at Lvmh Moet Hennessy Louis Vuitton SE bought 66,441 shares at 526.777EUR and the significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the...
LVMH: Share transactions disclosure Paris, February 24th, 2026 The disclosure of share transactions carried out from February 16th to February 20th, 2026, was sent to the AMF on February 24th, 2026. As required by current law, this document is publically available and can be consulted on the Company’s website () under the section «regulated information». LVMH LVMH Moët Hennessy Louis Vuitton is represented in Wines and Spirits by a portfolio of brands that includes Moët & Chandon, Dom Pérignon, Veuve Clicquot, Krug, Ruinart, Mercier, Château d’Yquem, Domaine du Clos des Lambrays, Château...
LVMH : Déclaration des transactions sur actions propres Paris, le 24 février 2026 La déclaration des transactions sur actions propres réalisées du 16 au 20 février 2026 a été adressée à l’Autorité des Marchés Financiers le 24 février 2026. Ce document est tenu à la disposition du public dans les conditions prévues par la réglementation en vigueur et peut être consulté dans la rubrique «information réglementée» du site internet de la Société (). LVMH LVMH Moët Hennessy Louis Vuitton est présent dans les Vins & Spiritueux au travers notamment des Maisons Moët & Chandon, Dom Pérignon, Veu...
Progress on share buyback programme Progress on share buyback programme ING announced today that, as part of our €1.1 billion share buyback programme announced on 30 October 2025, in total 2,592,238 shares were repurchased during the week of 16 February up to and including 20 February 2026. The shares were repurchased at an average price of €24.59 for a total amount of €63,749,138.94. For detailed information on the daily repurchased shares, individual share purchase transactions and weekly reports, see the updates on the on our website. In line with the purpose of the programme to redu...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.